Positive Data for ARS Pharma - San Diego Business Journal
Is Needle-Free Epinephrine Coming Soon? - Allergic Living
Oliver's Choice - Food Allergies
NEFFY - ARS Pharmaceuticals, Inc. Trademark Registration
ARS Pharma's NDA accepted for neffy to treat allergic reactions of type I
Recordati Receive Exclusive Rights for ARS Pharmaceutical's Epinephrine Nasal Spray
ARS Pharmaceuticals on Twitter: "Patients have less than 30 minutes to act when they have a severe allergic reaction. ARS-1's newly approved patent allows for a decreased dosage level that helps ensure
Silverback Therapeutics and ARS Pharmaceuticals Announce Merger
Sprayable epinephrine “neffy” : r/ems
ARS Pharmaceuticals Raises $55 Million in Series D Funding for Launch Preparations of Neffy™ (epinephrine nasal spray) - Opera News
FDA accepts NDA for neffy intranasal epinephrine
Epinephrine nasal spray achieves pharmacodynamic responses comparable with injections
FDA accepts ARS' filing for nasal spray EpiPen rival for review
Neffy, INN-adrenaline
Product – ARS Pharma
ARS Pharmaceuticals (@ars_pharma) / Twitter
Un spray nasal pour lutter contre l'anaphylaxie : Neffy® Oasis-Allergies.org
FDA Accepts New Drug Application for Nasal Epinephrine Spray Treatment for Anaphylaxis | SnackSafely.com
Intranasal Epinephrine to Take Center Stage at 2022 AAAAI Annual Meeting | SnackSafely.com
Product – ARS Pharma
Epinephrine Nasal Spray Under Review for Emergency Tx of Severe Allergic Reactions
Main Line Allergy
Intranasal epinephrine: A potential substitute for injections? | Latest news for Doctors, Nurses and Pharmacists | Pharmacy
Allergy & Asthma Awareness Initiative - AAAI - Nasal epinephrine auto injectors are on the horizon! https://ars-pharma.com/ | Facebook
Merger Announcement
Meet Neffy, the friendly epinephrine nasal spray from ARS Pharma awaiting FDA approval | Fierce Pharma
SD-Rakete Silverback fusioniert – macht das Sinn? › sharedeals.de
